CNS & Neurological Disorders-Drug Targets

Papers
(The median citation count of CNS & Neurological Disorders-Drug Targets is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Neuroprotection of Rotenone-Induced Parkinsonism by Ursolic Acid in PD Mouse Model58
Role of Calcium Homeostasis in Ischemic Stroke: A Review46
Benzodiazepines and Sleep Architecture: A Systematic Review44
Inflammation and Mitochondrial Dysfunction in Autism Spectrum Disorder43
Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol35
Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment31
Role of Brain-Gut-Microbiota Axis in Depression: Emerging Therapeutic Avenues27
Role of Vitamins in Neurodegenerative Diseases: A Review26
Speech as a Biomarker for Depression24
Arachidonic Acid Derivatives and Neuroinflammation23
Levodopa Therapy for Parkinson's Disease: History, Current Status and Perspectives23
Valproic Acid and Propionic Acid Modulated Mechanical Pathways Associated with Autism Spectrum Disorder at Prenatal and Neonatal Exposure19
The MMP-2/TIMP-2 System in Alzheimer Disease19
ATP-sensitive Potassium Channel Subunits in Neuroinflammation: Novel Drug Targets in Neurodegenerative Disorders18
Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases18
Current Strategies and Novel Drug Approaches for Alzheimer Disease18
Modeling Parkinson’s Disease in Zebrafish18
The Effects and Regulatory Mechanism of Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi in Promoting Neurogenesis and Improving Memory Impairment Mediated by the BDNF-ERK-CREB Signa17
Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerations and Management in COVID-19 Pandemic17
Melatonin and Sleep Disturbances in Alzheimer’s Disease17
Pharmacological Treatment of Diabetic Peripheral Neuropathy: An Update17
Smartphone Addiction among Students and its Harmful Effects on Mental Health, Oxidative Stress, and Neurodegeneration towards Future Modulation of Anti-Addiction Therapies: A Comprehensive Survey base16
Arachidonic Acid Metabolites in Neurologic Disorders16
Neural Basis of Dental Pulp Stem Cells and its Potential Application in Parkinson’s Disease16
Microglial Cathepsin B and Porphyromonas gingivalis Gingipains as Potential Therapeutic Targets for Sporadic Alzheimer’s Disease16
Lipid Nanocarriers for Neurotherapeutics: Introduction, Challenges, Blood-brain Barrier, and Promises of Delivery Approaches16
Carvacrol as a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article15
Detection, Treatment Planning, and Genetic Predisposition of Bruxism: A Systematic Mapping Process and Network Visualization Technique15
Sepsis-Associated Encephalopathy: Insight into Injury and Pathogenesis15
An Insight into Molecular Mechanisms and Novel Therapeutic Approaches in Epileptogenesis15
Markers of Neuroinflammation in the Serum of Prepubertal Children with Fetal Alcohol Spectrum Disorders14
Role of Natural Plant Products Against Alzheimer’s Disease14
Neurological Associations of SARS-CoV-2 Infection: A Systematic Review14
Intracerebral Hemorrhage and Diabetes Mellitus: Blood-Brain Barrier Disruption, Pathophysiology and Cognitive Impairments14
Novel Targets Explored in the Treatment of Alcohol Withdrawal Syndrome14
Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases13
Nanoparticles as Powerful Tools for Crossing the Blood-brain Barrier13
Tremor and Rigidity in Patients with Parkinson’s Disease: Emphasis on Epidemiology, Pathophysiology and Contributing Factors13
Tumor Treating Fields – Behind and Beyond Inhibiting the Cancer Cell Cycle12
Understanding Abnormal c-JNK/p38MAPK Signaling in Amyotrophic Lateral Sclerosis: Potential Drug Targets and Influences on Neurological Disorders12
Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?12
GluN2B/N-methyl-D-aspartate Receptor Antagonists: Advances in Design, Synthesis, and Pharmacological Evaluation Studies12
Neuroprotective and Anti-Inflammatory Effects of Pioglitazone on Parkinson's Disease: A Comprehensive Narrative Review of Clinical and Experimental Findings12
Rethinking Catatonia: New Insights from the Autism Spectrum11
Structural Activity Relationship based Medicinal Perspectives of Pyrimidine Derivatives as Anti-Alzheimer’s Agents: A Comprehensive Review11
Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review11
Dopamine as a Potential Target for Learning and Memory: Contributing to Related Neurological Disorders11
The locus of Action of CGRPergic Monoclonal Antibodies Against Migraine: Peripheral Over Central Mechanisms11
Migraine and Obesity: Is There a Relationship? A Systematic Review and Meta-Analysis of Observational Studies11
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO11
Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi Regulate the Brain Tau Hyperphosphorylation at Multiple Sites Induced by Composited Aβ in Rats11
The Development of a PBPK Model for Atomoxetine Using Levels in Plasma, Saliva and Brain Extracellular Fluid in Patients with Normal and Deteriorated Kidney Function11
MCC950 Reduces Neuronal Apoptosis in Spinal Cord Injury in Mice11
Intestinal Barrier Dysfunction Participates in the Pathophysiology of Ischemic Stroke10
Beyond the Obvious: Smoking and Respiratory Infection Implications on Alzheimer's Disease10
Transdermal Drug Delivery Systems and their Potential in Alzheimer’s Disease Management10
Improvement of a Novel Proposal for Antioxidant Treatment Against Brain Damage Occurring in Ischemic Stroke Patients10
Beta-Caryophyllene, a CB2R Selective Agonist, Protects Against Cognitive Impairment Caused by Neuro-inflammation and Not in Dementia Due to Ageing Induced by Mitochondrial Dysfunction10
Drosophila melanogaster a Versatile Model of Parkinson’s Disease10
A Causal-Pathway Phenotype of Chronic Fatigue Syndrome due to Hemodialysis in Patients with End-Stage Renal Disease10
Nanoparticles Based Intranasal Delivery of Drug to Treat Alzheimer’s Disease: A Recent Update10
Resolution-Associated Molecular Patterns (RAMPs) as Endogenous Regulators of Glia Functions in Neuroinflammatory Disease9
Regulatory Role of Chinese Herbal Medicine in Regulated Neuronal Death9
Cenobamate: A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability Profile in the Treatment of Epilepsy9
Dietary Nutrients and Prevention of Alzheimer’s Disease9
Design and Microwave-Assisted Synthesis of Aza-Resveratrol Analogs with Potent Cholinesterase Inhibition9
Neurokinin-1 Receptor Antagonist Reverses Functional CNS Alteration Caused by Combined γ-rays and Carbon Nuclei Irradiation9
Deciphering the Role of Aberrant Protein Post-Translational Modification in the Pathology of Neurodegeneration9
In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity9
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health9
The Mechanism of Action of Salsolinol in Brain: Implications in Parkinson’s Disease9
Spastin Interacts with CRMP2 to Regulate Neurite Outgrowth by Controlling Microtubule Dynamics through Phosphorylation Modifications9
The Protective Effect of Vitexin Compound B-1 on Rat Cerebral I/R Injury through a Mechanism Involving Modulation of miR-92b/NOX4 Pathway8
Oxytocin Effect in Adult Patients with Autism: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials8
Circular RNAs in Alzheimer’s Disease: A New Perspective of Diagnostic and Therapeutic Targets8
Importance of Zebrafish as an Efficient Research Model for the Screening of Novel Therapeutics in Neurological Disorders8
Nanotechnology: Its Application in Treating Neurodegenerative Diseases8
A Critical Analysis of Quercetin as the Attractive Target for the Treatment of Parkinson's Disease8
Effects of α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator on BDNF, NKCC1 and KCC2 Expression in the Hippocampus following Lipopolysaccharide-Induced Allodynia and Hyperalgesia in a 8
Neurorestoratology: New Advances in Clinical Therapy8
Dopaminergic Signaling as a Plausible Modulator of Astrocytic Toll-Like Receptor 4: A Crosstalk between Neuroinflammation and Cognition8
Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease8
Quantitative Characterization of Phenotypical Markers After Differentiation of SH-SY5Y Cells8
Rationalizing the Use of Polyphenol Nano-formulations in the Therapy of Neurodegenerative Diseases7
Age and Dose-Dependent Effects of Alpha-Lipoic Acid on Human Microtubule- Associated Protein Tau-Induced Endoplasmic Reticulum Unfolded Protein Response: Implications for Alzheimer’s Disease7
Comparison of the Sedative Effect of Ketamine, Magnesium Sulfate, and Propofol in Patients Undergoing Upper Gastrointestinal Endoscopy: Double-Blinded Randomized Clinical Trial7
Pharmacological and Pathological Relevance of S100 Proteins in Neurological Disorders7
Role of Forkhead Transcription Factors of the O Class (FoxO) in Development and Progression of Alzheimer’s Disease7
Rolipram Rescues Memory Consolidation Deficits Caused by Sleep Deprivation: Implication of the cAMP/PKA and cAMP/Epac Pathways7
Targeted Delivery of Montelukast for the Treatment of Alzheimer’s Disease7
Integrated System Pharmacology and In Silico Analysis Elucidating Neuropharmacological Actions of Withania somnifera in the Treatment of Alzheimer’s Disease7
Minocycline Inhibits mTOR Signaling Activation and Alleviates Behavioral Deficits in the Wistar Rats with Acute Ischemia stroke7
Targeting Microglial Polarization to Improve TBI Outcomes7
The Role of Statins in the Management of Delirium: Recent Advances7
Exploring the Various Aspects of Brain-Derived Neurotropic Factor (BDNF) in Diabetes Mellitus7
Blood-brain Barrier and Neurovascular Unit Dysfunction in Parkinson's Disease: From Clinical Insights to Pathogenic Mechanisms and Novel Therapeutic Approaches7
Non-hepatic Hyperammonemia: A Potential Therapeutic Target for Sepsis-associated Encephalopathy7
Nanotechnological Advances in the Treatment of Epilepsy7
Elucidations of Molecular Mechanism and Mechanistic Effects of Environmental Toxicants in Neurological Disorders7
The AMPAR Antagonist Perampanel Regulates Neuronal Necroptosis via Akt/GSK3β Signaling After Acute Traumatic Injury in Cortical Neurons7
Drosophila: A Model to Study the Pathogenesis of Parkinson’s Disease7
Lactose and Casein Cause Changes on Biomarkers of Oxidative Damage and Dysbiosis in an Experimental Model of Multiple Sclerosis7
Neuroprotective Role of the B Vitamins in the Modulation of the Central Glutamatergic Neurotransmission7
Mechanistic Insight and Possible Mechanism of Seizure in Covid-19: The Nuances and Focal Points7
Management of Impulse Control Disorders with Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease7
A Review on Autism Spectrum Disorder: Pathogenesis, Biomarkers, Pharmacological and Non-Pharmacological Interventions7
Anaesthesia-induced Changes in Genomic Expression Leading to Neurodegeneration7
Transdermal Nutraceuticals Delivery System for CNS Disease7
Role of Potassium Ion Channels in Epilepsy: Focus on Current Therapeutic Strategies6
A Concise Review of Common Plant-derived Compounds as a Potential Therapy for Alzheimer's Disease and Parkinson's Disease: Insight into Structure-Activity-Relationship6
Natural Products as Bioactive Agents in the Prevention of Dementia6
Nanomedicinal Strategies as Emerging Therapeutic Avenues to Treat and Manage Cerebral Ischemia6
Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease6
Modulation of Huntington’s Disease in Drosophila6
Anti-Neuropathic Pain Activity of Ageratum conyzoides L due to the Essential Oil Components6
Impact of Cannabis-Based Medicine on Alzheimer’s Disease by Focusing on the Amyloid β-Modifications: A Systematic Study6
Ethanolamine: A Potential Promoiety with Additional Effects on the Brain6
Phytotherapeutics against Alzheimer’s Disease: Mechanism, Molecular Targets and Challenges for Drug Development6
Effectiveness and Safety Profile of Ginkgo biloba Standardized Extract (EGb761®) in Patients with Amnestic Mild Cognitive Impairment6
Biomarker Validation of a New Case Definition of Menstrual Cycle-Associated Syndrome (MCAS) Opinion Paper6
Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer’s Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer’s Disease6
Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond O-6-Methylguanine-DNA Methyltransferase6
Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia6
APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease6
Immunotherapies for Parkinson’s Disease: Progression of Clinical Development6
Herbal Approaches in the Management of Mental Depression6
An Overview of Acute Flaccid Myelitis5
Cellular and Molecular Mechanisms of Dementia: Decoding the Causal link of Diabetes Mellitus in Alzheimer’s Disease5
An Insight into the Role of Artificial Intelligence in the Early Diagnosis of Alzheimer’s Disease5
Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia5
Pharmacotherapeutic Potential of Garlic in Age-Related Neurological Disorders5
A Review on Pathophysiological Aspects of Sleep Deprivation5
Myasthenia Gravis and Vitamin D Serum Levels: A Systematic Review and Meta-analysis5
Liver-Brain Axis in Sporadic Alzheimer’s Disease: Role of Ten Signature Genes in a Mouse Model5
1,3,5-Pyrazoline Derivatives in CNS Disorders: Synthesis, Biological Evaluation and Structural Insights through Molecular Docking5
Inter/Transgenerational Effects of Drugs of Abuse: A Scoping Review5
Histone Deacetylase Inhibitors Prevented the Development of Morphine Tolerance by Decreasing IL6 Production and Upregulating μ-Opioid Receptors5
Importance of Exploring N-Methyl-D-Aspartate (NMDA) as a Future Perspective Target in Depression5
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives5
Targeting Brain Cancer Cells by Nanorobot, a Promising Nanovehicle: New Challenges and Future Perspectives5
Fibrosis and Regulation of Nerve Regeneration in the Peripheral and Central Nervous Systems5
Effect of Apigenin on Neurodegenerative Diseases5
COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration?5
Radiotherapy and Its Impact on the Nervous System of Cancer Survivors5
The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety5
The Endocannabinoid System and Alcohol Dependence: Will Cannabinoid Receptor 2 Agonism be More Fruitful than Cannabinoid Receptor 1 Antagonism?5
The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease5
Current Drug Targets in Alzheimer’s Associated Memory Impairment: A Comprehensive Review5
Neuroprotective effect of 3,3′-diindolylmethane and ɑ-naphthoflavone, aryl hydrocarbon receptor modulators in an experimental model of ischemic stroke5
Cardiac Biomarkers in Stroke, Alzheimer’s Disease, and Other Dementia. Are They of Use? A Brief Overview of Data from Recent Investigations5
Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps5
Epigenetic Basis of Psychiatric Disorders: A Narrative Review5
CGRP and CGRP-Receptor as Targets of Migraine Therapy: Brain Prize-20214
Zederone Improves the Fecal Microbial Profile in Dementia Induced Rat Model: A First Report4
A Systematic Review of Updated Mechanistic Insights Towards Alzheimer’s Disease4
COVID-19 Outbreak: Neurological Manifestations Beyond Cough and Fever4
Danshensu Enhances Cerebral Angiogenesis in Mice by Regulating the PI3K/Akt/Mtor/VEGF Signaling Axis4
Conifer Essential Oils Reversed Amyloid Beta1-42 Action by Modulating BDNF and ARC Expression in The Rat Hippocampus4
The Current Evidence for the Therapeutic Role of Curcumin in Alzheimer’s Disease4
Berberine Ameliorates Cognitive Impairment by Regulating Microglial Polarization and Increasing Expression of Anti-inflammatory Factors following Permanent Bilateral Common Carotid Artery Occlusion in4
Role of G-Proteins and GPCR-Mediated Signalling in Neuropathophysiology4
Is There a Role of Vitamin D in Alzheimer’s Disease?4
Hematological Consequences of Valproic Acid in Pediatric Patients: A Systematic Review with a Mechanistic Approach4
Intriguing Role of Gut-Brain Axis on Cognition with an Emphasis on Interaction with Papez Circuit4
High-frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Accelerates onset Time of Beneficial Treating Effects and Improves Clinical Symptoms of Depression4
Dipsacoside B Exerts a Beneficial Effect on Brain Injury in the Ischemic Stroke Rat through Inhibition of Mitochondrial E3 Ubiquitin Ligase 14
Neuroprotective Efficacy of Edaravone against Arsenic-Induced Behavioral and Neurochemical Deficits in Rats: Amelioration of Cholinergic and Mitochondrial Functions4
A Comprehensive Review on Therapeutic Potential of Chrysin in Brain Related Disorders4
A Comprehensive Review of the Docking Studies of Chalcone for the Development of Selective MAO-B Inhibitors4
Effective Connectivity Between the Orbitofrontal Cortex and the Precuneus Differentiates Major Psychiatric Disorders: Results from a Transdiagnostic Spectral DCM Study4
The Retrotransposition of L1 is Involved in the Reconsolidation of Contextual Fear Memory in Mice4
A Novel Approach to Refractory Epilepsy by Targeting Pgp Peripherally and Centrally: Therapeutic Targets and Future Perspectives4
Selective Inhibition of Soluble TNF using XPro1595 Improves Hippocampal Pathology to Promote Improved Neurological Recovery Following Traumatic Brain Injury in Mice4
In Vivo Antidepressant Efficacy of 3-Substituted Thietane-1,1-dioxide Derivative - A Preliminary Study for Novel Anti-Depression Therapy in Neurological Disorders4
Anti-neuropathic Pain Mechanistic Study on A. conyzoides Essential Oil, Precocene II, Caryophyllene, or Longifolene as Single Agents and in Combination with Pregabalin4
Modifiable Risk Factors Associated with Alzheimer’s Disease with Special Reference to Sleep Disturbance4
Magic Shotgun Nature with Scattergun Approach of Curcumin Repurposing in Obsessive-compulsive Disorder: A Novel Metaphysician of Drug Discovery4
Restless Leg Syndrome in Patients with Liver Cirrhosis! Its Frequency, Severity, and Correlation4
Sex-Related Differences in Polygraphic Parameters in a Population of Patients with Obstructive Sleep Apnea Syndrome4
The Protective Effects of Pioglitazone Against Cognitive Impairment Caused by L-methionine Administration in a Rat Model4
Elucidating the Role of Trauma and Significant Life Stress in the Disease of Addiction may Provide New Targets for Medication Development4
Brain Damage in the Preterm Infant: Clinical Aspects and Recent Progress in the Prevention and Treatment3
An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease3
Impact of COVID-19 on Anxiety and Depression - Biopsychosocial Factors3
A Review of Antidepressant Effects and Mechanisms of Three Common Herbal Medicines: Panax ginseng, Bupleurum chinense, and Gastrodia elata3
Neuroregenerative Activity of the Dipeptide Mimetic of Brain-derived Neurotrophic Factor GSB-106 Under Experimental Ischemic Stroke3
Emerging Promise of Phytochemicals in Ameliorating Neurological Disorders3
Decoding the Inter-Relationship between Sleep Disorders and Alzheimer’s Disease Pathogenesis3
Hypomyelination with Atrophy of Basal Ganglia and Cerebellum (HABC) Due to UFM1 Mutation in Roma Patients - Severe Early Encephalopathy with Stridor and Severe Hearing and Visual Impairment. A Single 3
Lithium Cholesterol Sulfate: A Novel and Potential Drug for Treating Alzheimer’s Disease and Autism Spectrum Disorder3
Therapeutic Effects of Thymoquinone on Alzheimer’s Disease through Modulating Amyloid-beta Neurotoxicity and Neuro-inflammatory Cytokine Levels3
Apoptosis in the Dentate Nucleus Following Kindling-induced Seizures in Rats3
Eugenol Elicits Prolongevity by Increasing Resistance to Oxidative Stress in C. elegans3
Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer’s Disease3
SARS-CoV-2 Infection to Premature Neuronal Aging and Neurodegenerative Diseases: Is there any Connection with Hypoxia?3
Bumetanide, a Diuretic That Can Help Children with Autism Spectrum Disorder3
Immunotherapy for Pediatric Gliomas: CAR-T Cells Against B7H3: A Review of the Literature3
Mini Review on Cariprazine: A Promising Antipsychotic Agent3
Mini-Review on SARS-CoV-2 Infection and Neurological Manifestations: A Perspective3
Mechanisms Involved in Neuroprotective Effects of Transcranial Magnetic Stimulation3
Perspective on Cav-1 for its Potential as Newer Therapeutics for Parkinson’s Disease3
Psychiatric Manifestations of COVID-19: A Literature Review3
Epigenetic Modifications by Estrogen and Androgen in Alzheimer’s Disease3
Bell Palsy: Facts and Current Research Perspectives3
Comparing the Efficacy and Safety of Dexmedetomidine/Ketamine with Propofol/Fentanyl for Sedation in Colonoscopy Patients: A Doubleblinded Randomized Clinical Trial3
The Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer’s Disease3
Treatment of Catatonia with Asenapine in a Patient with Schizotypal Personality Disorder, Psychotic Depression and Septic Shock from SARSCoV- 2 - A Case Report3
The Role of Monoamine Oxidase B Inhibitors in the Treatment of Parkinson’s Disease - An Update3
Evaluation of Associated Genes with Traumatic Pain: A Systematic Review3
Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson’s Disease3
Lorcaserin: Worthy of Further Insights? Results from Recent Research3
A Systematic Review on the Role of Arachidonic Acid Pathway in Multiple Sclerosis3
Plants and their Bioactive Compounds as a Possible Treatment for Traumatic Brain Injury-Induced Multi-Organ Dysfunction Syndrome3
A Comprehensive Study of miRNAs in Parkinson’s Disease: Diagnostics and Therapeutic Approaches2
Clinical Onset of Action of Incobotulinum Toxin A Preparation2
Neurological Complications Caused by Human Immunodeficiency Virus (HIV) and Associated Opportunistic Co-infections: A Review on their Diagnosis and Therapeutic Insights2
Acute Phenobarbital Poisoning for the Management of Seizures in Newborns and Children; A Systematic Literature Review2
Cellular Senescence and ApoE4: Their Repercussions in Alzheimer’s Disease2
Emerging Nanotechnology for the Treatment of Alzheimer’s Disease2
Reciprocal Interaction of Pain and Brain: Plasticity-induced Pain, Pain-induced Plasticity, and Therapeutic Targets2
Atorvastatin Prevents the Neuron Loss in the Hippocampal Dentate Gyrus Region through its Anti-Oxidant and Anti-Apoptotic Activities2
Interactions between Ketamine and Magnesium for the Treatment of Pain: Current State of the Art2
The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson’s Disease in Zebrafish: The Current Applications and Perspectives2
The Effects of Vitamin Therapy on ASD and ADHD: A Narrative Review2
Highlighting the Protective or Degenerative Role of AMPK Activators in Dementia Experimental Models2
Prevention of Parkinson’s Disease: From Risk Factors to Early Interventions2
The Outcomes of Small-Molecule Kinase Inhibitors and the Role of ROCK2 as a Molecular Target for the Treatment of Alzheimer's Disease2
Does Human Alpha-Synuclein Behave Like Prions?2
Dioclea Altissima Seed Lectin (DAL) Prevents Anxiety-like Behavioral Responses in Adult Zebrafish (Danio Rerio): Involvement of GABAergic and 5-HT Systems2
Deciphering the Influence of Cigarette Smoke Carcinogens on CNS Associated Biomolecules: A Computational Synergistic Approach2
Endophenotypes and Pathway Phenotypes in Neuro-psychiatry: Crossdisciplinary Implications for Diagnosis2
Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review2
Gene Therapy for Neuropsychiatric Disorders: Potential Targets and Tools2
Mycotoxins and Amyotrophic Lateral Sclerosis: Food Exposure, Nutritional Implications and Dietary Solutions2
Foresee Novel Targets for Alzheimer’s Disease by Investigating Repurposed Drugs2
Neuroprotective Potential of Bacopa monnieri: Modulation of Inflammatory Signals2
Cutaneomeningospinal Angiomatosis (Cobb Syndrome) in a Young Patient2
Sleep Disorders Research From 1945 to 2020: A Bibliometric Analysis2
Exploring the Hypothesis of a Schizophrenia and Bipolar Disorder Continuum: Biological, Genetic and Pharmacologic Data2
Strategic Approaches to Target the Enzymes using Natural Compounds for the Management of Alzheimer’s Disease: A Review2
Melatonin Alleviates Pyroptosis of Retinal Neurons Following Acute Intraocular Hypertension2
Anti-seizure Medications: Challenges and Opportunities2
Circadian Rhythms and Sleep Disorders Associated to Major Depressive Disorder: Pathophysiology and Therapeutic Opportunities2
Low Serum Levels of Fibroblast Growth Factor 2 in Gunn Rats: A Hyperbilirubinemia Animal Model of Schizophrenic Symptoms2
Na+/HCO3− Co-transporters Inhibitor S0859 Attenuates Global Cerebral Ischemia-reperfusion Injury of the CA1 Neurons in the Gerbil’s Hippocampus2
Common microRNAs in Epilepsy and Migraine: Their Possibility as Candidates for Biomarkers and Therapeutic Targets during Comorbid Onset of Both Conditions2
Impact of Dimethylfumarate on Sleep in Multiple Sclerosis Patients: An Actigraphic Study2
Experimental Rodent Models of Vascular Dementia: A Systematic Review2
Hair Cortisol Concentration as a Biomarker of Symptoms of Depression in the Perinatal Period2
Coenzyme Q10 in the Treatment of Attention Deficit Hyperactivity Disorder in Children: A Randomized Controlled Trial2
0.050580024719238